TD Cowen Reiterates Buy Rating on EyePoint Pharmaceuticals, Inc. (EYPT)
Tweet Send to a Friend
TD Cowen analyst Ken Cacciatore reiterated a Buy rating and $20.00 price target on EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT)The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
